GW Pharmaceuticals Plc Stock, NASDAQ:GWPH
Sovereign House, Vision Park, Chivers Way, Cambridge, Cambridgeshire CB24 9BZ
Number of Employees: 901
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.